Update on Business Immunity to COVID-19 Lawsuits

by Nick Bayard, President & CEO, Bayard Consulting At a quarter of a trillion dollars, the market for impact investing is enormous and rapidly growing. Investors who expect a double or triple bottom line are expecting those who steward their…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team working on behalf of a pharmaceutical company wanted to better understand how anti-cancer pharmaceuticals are evaluated for inclusion on payer prescription lists. They were conducting strategy research and needed a large volume of experts…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Mani Padmanabhan, CFO and Co Founder at Price Eagle Online We are living in a globalized, hyper-connected world with faster and easier information access. Laws are increasingly becoming stronger and trans-jurisdictional every day. The enforcement actions are becoming stronger,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A senior scientist at a large medical device company wanted to connect with Research & Development (R&D) engineers, scientists, clinicians, and chemists who focus on drug delivery or drug-eluting systems for implantable medical devices. This included antibacterial…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Marc Fischer, Co-Founder and CEO of Dogtown Media Brace yourselves for impact. Humanity is on the brink of a fourth industrial revolution thanks to machine learning. This subset of artificial intelligence (AI) is unlocking unprecedented value across every industry,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a major consulting firm was conducting due diligence for a private equity case on practice management IT solutions. They needed to speak with experts working in the industry, as well as IT decision-makers…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Hans Lagerweij, CEO and President of Victory Cruise Lines Expedition cruising is a fast-developing travel segment. Thirty-two new expedition ships are on order, with an estimated investment of over $4 billion. The big question is if the market growth…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a major consulting firm was conducting due diligence for a private equity case on practice management IT solutions. They needed to speak with experts working in the industry, as well as IT decision-makers…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Richard Saxon, Principal at Consultancy For The Built Environment If you are a building owner, you are probably missing out on the full advantages of going digital. Real Estate and Construction are laggard sectors in adopting technologies which can…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Ken Powell, President, Genesis Business Development The objective of companion diagnostics (CDx) is to maximize that a patient with a particular disease state has the highest probability of responding to a given therapeutic. CDx is now in its second…

Read More